An outcome study of the RTOG Cancer Control program

Area of Science:

• Oncology
• Clinical Trials
• Health Services Research

Background:

• The National Cancer Institute's Cancer Control program aimed to integrate community hospitals into multi-institutional clinical trials.
• The Radiation Therapy Oncology Group (RTOG) joined this initiative in 1976, involving both major treatment centers (Full Members) and community hospitals (Cancer Control members).

Purpose of the Study:

• To compare patient survival outcomes between RTOG Full Member institutions and Cancer Control institutions.
• To assess if community hospitals participating in the Cancer Control program achieved similar survival rates as major cancer centers within RTOG studies.

Main Methods:

• A comparative analysis of survival data from five RTOG studies conducted between 1976 and 1985.
• Evaluation included overall survival and survival adjusted for known prognostic factors.
• Data quality and protocol compliance were assessed between the two types of institutions.

Main Results:

• No significant differences in overall patient survival were observed between patients treated at Full Member institutions and Cancer Control institutions.
• Survival comparisons, even after adjusting for prognostic factors, showed no disparities.
• Data quality and protocol compliance were found to be equivalent across both types of participating hospitals.

Conclusions:

• Community hospitals participating in the Cancer Control program deliver comparable patient survival outcomes to major cancer centers within the RTOG framework.
• The Cancer Control program successfully facilitated equitable participation and outcomes in multi-institutional clinical trials.
• Findings support the integration of community hospitals in national cancer clinical trial networks.